The Cardiac Valve Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Cardiac Valve Market:
https://www.thebusinessresearchcompany.com/report/cardiac-valve-global-market-report
According to The Business Research Company’s Cardiac Valve Global Market Report 2024, The cardiac valve market size has grown rapidly in recent years. It will grow from $9.68 billion in 2023 to $11.17 billion in 2024 at a compound annual growth rate (CAGR) of 15.3%. The growth in the historic period can be attributed to aging population and the associated increase in valvular heart disease, growth in the prevalence of risk factors like obesity and hypertension, improved diagnostic and imaging technologies for valve diseases, awareness campaigns and education on heart health and valve disease, and development of minimally invasive and transcatheter valve procedures.
The cardiac valve market size is expected to see rapid growth in the next few years. It will grow to $18.87 billion in 2028 at a compound annual growth rate (CAGR) of 14.0%. The growth in the forecast period can be attributed to increasing demand for bioengineered and tissue-engineered heart valves, aging global population and the need for valve disease treatment, telemedicine and remote patient monitoring for valve patients, enhanced surgical techniques and robotics-assisted valve procedures, and adoption of 3d printing for personalized heart valve manufacturing. Major trends in the forecast period include advancements in valve replacement and repair techniques, integration of artificial intelligence (ai) for valve disease detection and treatment planning, adoption of 3d printing for personalized heart valve manufacturing, advancements in valve replacement and repair techniques, and enhanced surgical techniques and robotics-assisted valve procedures.
The rising incidence of cardiovascular diseases is expected to propel the growth of the cardiac valve market. The prevalence of cardiovascular disease has gradually increased due to smoking, obesity, a lack of physical activity, and other factors that strain the cardiovascular system. The most common cause of coronary artery disease is arteries’ build-up of fatty plaques. These gradual increases in heart-related diseases raised the demand for the cardiac valve to treat heart valve problems. For instance, in September 2023, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations, there were 41 million deaths, which is 74% of those caused by non-communicable diseases (NCDs) or chronic diseases every year globally. There were 17.9 million deaths from cardiovascular diseases, 9.3 million deaths from cancer, 4.1 million deaths from chronic respiratory diseases, and 2.0 million deaths from diabetes. . Therefore, the rising incidence of cardiovascular diseases will drive the growth of the cardiac valve market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=7753&type=smp
The cardiac valve market covered in this report is segmented –
1) By Type: Tissue Heart Valves, Transcatheter Heart Valves, Mechanical Heart Valves, Other Types
2) By Position: Aortic Valve, Mitral Valve, Other Positions
3) By Treatment: Cardiac Valve Repair, Cardiac Valve Replacement
4) By End-Users: Hospital And Clinics, Specialty Centers, Cardiac Research Institute, Other End Users
Top Major Players
LivaNova PLC
Abbott Laboratories
Colibri Heart Valve LLC
TTK HealthCare Limited
Artivion Inc.
Technological advancements in cardiac valves are a key trend gaining popularity in the cardiac valve market. With advancements in technology, there are less invasive treatment options for heart diseases. Major companies operating in the cardiac valve market are concentrating on technologies such as neochordae implantation, annuloplasty ring, and robotic surgery to strengthen their market position. These innovative technologies help to protect patients from life-threatening conditions such as heart stroke and cardiac arrest. For instance, in September 2022, Edwards, a US-based medical technology company launched Sapien 3 Ultra Resilia transcatheter heart valve with anti-calcification technology. This technology platform was developed to irreversibly block calcium binding sites in bioprosthetic valves. .
The cardiac valve market report table of contents includes:
1. Executive Summary
2. Cardiac Valve Market Characteristics
3. Cardiac Valve Market Trends And Strategies
4. Cardiac Valve Market – Macro Economic Scenario
5. Global Cardiac Valve Market Size and Growth
…………………….
31. Global Cardiac Valve Market Competitive Benchmarking
32. Global Cardiac Valve Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Cardiac Valve Market
34. Cardiac Valve Market Future Outlook and Potential Analysis
35. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
